Obstela 10 mg
| SKU | 2624 |
|---|---|
| Generic For | Ocaliva |
| Manufacturer | Sun Pharmaceuticals Ltd |
| Active Ingredient | Obeticholic Acid |
Out Of Stock
Obstela 10 mg (Obeticholic Acid) – Affordable Ocaliva Alternative
What is Obeticholic Acid and what condition does it treat?
Obeticholic Acid is a farnesoid X receptor (FXR) agonist used primarily to treat primary biliary cholangitis (PBC), a chronic liver disease that damages bile ducts. Marketed under the brand name Obstela 10 mg, this bile acid analogue helps improve liver function in adults with PBC who have an inadequate response to ursodeoxycholic acid (UDCA) or cannot tolerate UDCA. This prescription liver therapy works by reducing bile acid accumulation and inflammation in the liver, slowing disease progression and helping manage symptoms associated with this autoimmune condition.
How does Obeticholic Acid work in the body?
Obeticholic Acid works by activating the farnesoid X receptor (FXR), a nuclear receptor found in high concentrations in the liver and intestines. When Obstela 10 mg binds to these receptors, it regulates bile acid synthesis, transport, and metabolism. This FXR agonist reduces the production of bile acids while increasing their removal from the liver, decreasing toxic bile acid buildup that damages liver cells in primary biliary cholangitis. Additionally, this hepatoprotective medication has anti-inflammatory and anti-fibrotic effects, helping to preserve liver tissue and slow the progression of chronic liver disease.
How long does Obstela 10 mg take to work?
Obstela 10 mg typically begins affecting liver biochemistry within weeks, though noticeable improvements in liver enzyme levels generally appear after one to three months of consistent treatment. For patients with primary biliary cholangitis, the bile acid modulator demonstrates peak effectiveness after six to twelve months of therapy. Clinical studies show that Obeticholic Acid reduces alkaline phosphatase (ALP) levels—a key marker of liver inflammation—progressively over time. Since this is a disease-modifying liver treatment rather than a symptom reliever, patience is essential. Your healthcare provider will monitor blood tests regularly to assess response.
When and how should I take Obstela 10 mg?
Take Obstela 10 mg exactly as prescribed by your doctor, typically once daily with or without food. Most patients begin with a 5 mg dose, which may be increased to 10 mg after several months if tolerated and needed. Swallow the tablet whole with water at the same time each day to maintain consistent levels of Obeticholic Acid in your system. If you miss a dose of this PBC medication and remember within a few hours, take it immediately; otherwise skip it and resume your regular schedule. Never double doses. Your physician will adjust dosing based on liver function tests and how you tolerate treatment.
Is Obstela 10 mg safe for long-term use?
Obstela 10 mg is designed for long-term use in managing primary biliary cholangitis, a chronic progressive liver disease requiring ongoing treatment. Clinical trials extending several years have demonstrated that Obeticholic Acid maintains its safety profile with continued use when properly monitored. Regular blood tests are essential to assess liver function and adjust dosing appropriately. The most common long-term concern is pruritus (itching), which often improves over time or with dose adjustment. Patients with advanced cirrhosis or decompensated liver disease require careful monitoring, as this bile acid analogue may require dosage modification based on liver health status.
Can I take Obstela 10 mg with other medicines?
Obstela 10 mg can interact with certain medications, so inform your doctor about all drugs and supplements you take. Bile acid sequestrants like cholestyramine or colestipol should be taken at least four to six hours before or after Obeticholic Acid, as they can reduce absorption of this FXR agonist. Warfarin and other anticoagulants may require monitoring since this liver therapy can affect clotting factors. Medications metabolized by certain liver enzymes might need adjustment. Most patients with primary biliary cholangitis continue taking ursodeoxycholic acid (UDCA) alongside this treatment without issues, creating a complementary therapeutic approach.
How does Obstela 10 mg compare to similar medicines in its class?
Obstela 10 mg (Obeticholic Acid) is currently the only FDA-approved FXR agonist for treating primary biliary cholangitis, making it unique rather than having direct competitors within the same medication class. It differs from ursodeoxycholic acid (UDCA), the first-line PBC treatment, as a bile acid derivative with a different mechanism targeting farnesoid X receptors. While UDCA works by replacing toxic bile acids with less harmful ones, this next-generation bile acid therapy actively regulates bile acid metabolism and has anti-inflammatory properties. For patients with inadequate UDCA response, Obeticholic Acid offers a distinct therapeutic option with proven efficacy in reducing liver disease markers.
Is generic Obeticholic Acid as effective as branded versions?
Generic Obeticholic Acid contains the same active pharmaceutical ingredient in identical strength as branded Obstela 10 mg and must meet rigorous regulatory standards for bioequivalence, meaning it works identically in the body. Generic versions of this FXR agonist deliver the same therapeutic benefits for primary biliary cholangitis treatment at typically lower costs. Regulatory authorities in the USA, UK, Canada, and Australia require generic liver medications to demonstrate the same quality, safety, and efficacy as brand-name products. Whether you choose branded Obstela or generic Obeticholic Acid, you receive equivalent disease-modifying therapy for PBC when sourced from licensed pharmacies.
Why do patients choose PremiumRxDrugs for Obstela 10 mg?
Patients select PremiumRxDrugs for their Obstela 10 mg prescriptions because of transparent, competitive pricing on this specialised liver medication, often significantly lower than local pharmacy costs. As a licensed international pharmacy, we guarantee authentic Obeticholic Acid sourced directly from manufacturers, eliminating concerns about counterfeit products. Convenient features include easy prescription management, simple reordering for chronic conditions like primary biliary cholangitis, and discreet packaging that respects your privacy. With free shipping to the USA, UK, Australia, Canada, and worldwide, plus over 10 years of serving patients with complex medication needs, PremiumRxDrugs combines affordability, reliability, and customer-focused service for long-term FXR agonist therapy.
What are the common side effects of Obeticholic Acid?
The most common side effect of Obeticholic Acid is pruritus (itching), affecting many patients taking this FXR agonist for primary biliary cholangitis. This itching ranges from mild to moderate and may improve with continued use or dose adjustment. Other frequent reactions include fatigue, abdominal pain or discomfort, joint pain, dizziness, and constipation. Some patients experience rash or eczema-like skin changes. Elevated liver enzymes occasionally occur, which is why regular monitoring is important during treatment. Most side effects are manageable and decrease over time as your body adjusts to this bile acid therapy. Severe itching can sometimes require dosage reduction.
Who should avoid taking Obeticholic Acid?
Patients with complete biliary obstruction should not take Obeticholic Acid, as this FXR agonist requires functioning bile ducts to work safely. Those with decompensated cirrhosis (advanced liver failure with complications) face increased risks and require careful evaluation or may need to avoid this medication entirely. Pregnant or breastfeeding women should not use this PBC treatment due to potential harm to the baby. Individuals with known hypersensitivity to Obeticholic Acid or its components should avoid it. Patients with severely impaired liver function may require dose adjustment or alternative therapies. Always disclose your complete medical history, including liver disease severity, before starting any bile acid modulator.
Login
Sign Up
Login
Sign Up